Matthew A. Kutny, MD1, Todd A. Alonzo, PhD2, Yi-Cheng Wang, MS3*, Rhonda Ries, MA4*, Jason E. Farrar, M.D.5, Jaime M. Guidry Auvil, PhD6*, Malcolm A. Smith, MD, PhD7, Daniela S. Gerhard, PhD6*, Tanja M. Davidsen, PhD6*, Patee Gesuwan6*, Leandro C. Hermida6*, Marco A Marra, PhD8, Andrew J. Mungall, PhD9, Richard Moore, PhD8*, William Long, PhD9*, Yussanne Ma, PhD9*, Stuart Zong9*, E. Anders Kolb, MD10, Alan S. Gamis, MD, MPH11 and Soheil Meshinchi, MD, PhD4
1Department of Pediatrics, Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL
2Keck School of Medicine, University of Southern California, Los Angeles, CA
3Children's Oncology Group, Monrovia, CA
4Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
5Department of Pediatics/Hematology Oncology Section, University of Arkansas for Medical Sciences, Little Rock, AR
6Office of Cancer Genomics, National Cancer Institute, Bethesda, MD
7Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD
8Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada
9Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada
10Nemours Center for Cancer and Blood Disorders, Alfred I. duPont Hospital for Children, Wilmington, DE
11Division of Hematology/Oncology/Bone Marrow Transplantation, Children's Mercy Hospitals and Clinics, Kansas City, MO